Business

Physitrack PLC - Unaudited FY2025 Trading Update and Preliminary Results

Delivering a EUR 1.9m year-on-year improvement in free cash flow, reflecting a stronger, more focused and cash-generative SaaS business. LONDON, GB / ACCESS Newswire / January 29, 2026 / Physitrack PLC ("Physitrack" or the "Group")(STO:PTRK), a leading ...

articlePhysitrack LimitedJanuary 29, 20265/company/physitrack-limited/news/physitrack-plc-unaudited-fy2025-trading-update-and-preliminary-results
Physitrack PLC - Unaudited FY2025 Trading Update and Preliminary Results

About this update from Physitrack Limited

[{"type":"text","content":"Delivering a EUR 1.9m year-on-year improvement in free cash flow, reflecting a stronger, more focused and cash-generative SaaS business.","length":136,"tagName":"p"},{"type":"text","content":"LONDON, GB / ACCESS Newswire / January 29, 2026 / Physitrack PLC ("Physitrack" or the "Group")(STO:PTRK), a leading SaaS provider to the global physiotherapy and occupational health markets, today provides a preliminary, unaudited trading update on its financial performance for the fourth quarter and full year ended 31 December 2025.","length":355,"tagName":"p"},{"type":"text","content":"This announcement is intended to provide the market with an early indication of the Group's performance ahead of publication of the audited Annual Report on 27 February 2026. All figures are unaudited and subject to final audit adjustments.","length":244,"tagName":"p"},{"type":"text","content":"Physitrack delivered a material improvement in cash generation during FY2025, with free cash flow improving by approximately EUR 1.9 million year-on-year, moving from a cash outflow of approximately EUR 0.8 million in FY2024 to a cash inflow of approximately EUR 1.1 million in FY2025. This improvement reflects stronger underlying operating performance, disciplined cost control and improved working capital management. The prior year outflow included cash usage from discontinued operations (EUR 0.2 million), while FY2025 free cash flow relates to continuing operations, underscoring the strength of the Group's ongoing business.","length":636,"tagName":"p"},{"type":"text","content":"While revenue growth during the year was below management's long-term ambitions, margin expansion reflected deliberate strategic actions to simplify the Group, exit lower-margin activities and refocus on scalable, recurring SaaS revenues.","length":242,"tagName":"p"},{"type":"text","content":"Investor snapshot (unaudited)","length":29,"tagName":"p"},{"type":"text","content":"FY2025 summary","length":14,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"border:1px solid #DDDDDD;padding:2px 4px;text-align:justify;","val":[{"type":"text","content":"EUR m (unless stated)","length":21,"tagName":"p"}]},{"colspan":"1","rowspan":"1","style":"border:1px solid #DDDDDD;padding:2px 4px;text-align:justify;","val":[{"type":...

More updates from Physitrack Limited

free cash flowPhysitrack PLCRecurring revenuecash generationEBITDA margincash outflowrevenue